Search

everythinglearnresearchcommunity

for

Search:↓

Protein tyrosine kinases are key in male pattern baldness, affecting skin structure, hair growth, and immune responses.

MIM is crucial for hair follicle formation and regeneration by controlling cilia formation and hedgehog signaling through its interaction with Cortactin and Src.

Targeting the Smoothened receptor shows promise for treating certain cancers.

New small molecule drugs show promise in treating complex skin diseases but need more safety research.

Baicalin may help treat hair loss by promoting hair follicle growth and activating specific cellular pathways.

The hamster polyomavirus middle T antigen is linked to tumors in hamsters and associates with a specific tyrosine kinase.

Many patients on new leukemia drugs had mild to moderate skin reactions.

A new gene mutation may allow some piebaldism patients to regain skin color in white patches.

Certain leukemia drugs can cause severe skin reactions that may require stopping treatment.

Rapamycin may help treat Leigh syndrome by targeting protein kinase C.

Janus kinase inhibitors show promise in treating autoimmune skin diseases.

Retinoids increase steroid sulfatase activity in leukemia cells through RARα/RXR and involves certain pathways like phosphoinositide 3-kinase and ERK-MAP kinase.

JAK inhibitors show promise for treating various skin diseases.

The PDGF/PDGFR pathway is a potential drug target with mixed success in treating various diseases, including some cancers and fibrosis.

Vitamin D and its receptor regulate skin functions like cell growth, immunity, hair cycle, and tumor prevention.

Tyrosine kinases are important in skin autoimmune diseases and could be targets for new treatments.

Personalized treatments for hair loss focus on specific genetic and biological pathways.

Human dermal stem/progenitor cells can divide and differentiate more than hair follicle dermal papilla cells.

Certain tyrosine kinases may regulate hair growth and could help develop hair loss treatments.

A woman's hair turned white after taking a cancer drug called dasatinib.

Stem cells could improve hair growth and new treatments for baldness are being researched.

Some leukemia treatments can cause skin reactions similar to keratosis pilaris.

Skin cells produce and activate vitamin D, which regulates skin functions and supports hair growth.

Spanish experts provided guidelines for treating skin side effects in cancer patients on new therapies, stressing early action and teamwork.

Lack of KSR1 stops certain skin tumors in mice.

Targeted cancer therapies often cause skin reactions, so dermatologists must manage these effects.

Protein Kinase C shows promise for cancer treatment, but more research is needed to develop effective inhibitors.

Protein Kinase Cε increases skin sensitivity to UV damage and skin cancer risk.

Rapamycin treatment helps with mitochondrial disease by reducing PKC levels.

ILK and ELMO2 help cells move and stick together, important for wound healing and hair growth.